Review of treatment for late-life depression

Advances in Psychiatric Treatment

Volumn 19, Issue 4, 2013, Pages 302-309

  Allan, Charlotte L ^a   Ebmeier, Klaus P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; MIRTAZAPINE; NORTRIPTYLINE; SERTRALINE; VENLAFAXINE;

CONSTIPATION; DEMENTIA; DRUG INDICATION; DRUG TOLERABILITY; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED PRACTICE; HUMAN; HYPONATREMIA; LATE LIFE DEPRESSION; LONG QT SYNDROME; MENTAL HEALTH CARE; NERVE STIMULATION; PSYCHOTHERAPY; QT PROLONGATION; REVIEW; XEROSTOMIA;

EID: 84880857410     PISSN: 13555146     EISSN: 14721481     Source Type: Journal    
DOI: 10.1192/apt.bp.112.010835     Document Type: Review

References (79)

1. Alexopoulos GS, Meyers BS, Young RC, et al (1997) 'Vascular depression' hypothesis. Archives of General Psychiatry 54: 915-22.
2. Alexopoulos GS, Canuso CM, Gharabawi GM, et al (2008) Placebocontrolled study of relapse prevention with risperidone augmentation in older patients with resistant depression. American Journal of Geriatric Psychiatry 16: 21-30.
3. Alexopoulos GS, Kelly RE (2009a) Research advances in geriatric depression. World Psychiatry 8: 140-9.
4. Alexopoulos GS, Reynolds CF, Bruce ML, et al (2009b) Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. American Journal of Psychiatry 166: 882-90.
5. Alexopoulos GS (2011) Pharmacotherapy for late-life depression. Journal of Clinical Psychiatry 72(1): e04.
6. Allan CL, Ebmeier KP (2011a) The use of ECT and MST in treating depression. International Review of Psychiatry 23: 400-12.
7. Allan CL, Herrmann LL, Ebmeier KP (2011b) Transcranial magnetic stimulation in the management of mood disorders. Neuropsychobiology 64: 163-9.
8. Allan C, Kalu U-G, Sexton CE, et al (2012) Transcranial stimulation in depression. British Journal of Psychiatry 200: 10-1.
9. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA.
10. Anderson IM, Ferrier IN, Baldwin RC, et al (2008) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. Journal of Psychopharmacology 22: 343-96 (available at www.bap.org.uk/pdfs/antidepressants. pdf).
11. Apler A (2011) Citalopram for major depressive disorder in adults: a systematic review and meta-Analysis of published placebo-controlled trials. BMJ Open 1(2): e000106.
12. Bains J, Birks JS, Dening TR (2002) The efficacy of antidepressants in the treatment of depression in dementia. Cochrane Database of Systematic Reviews issue 4: CD003944.
13. Banerjee S, Hellier J, Dewey M, et al (2011) Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, doubleblind, placebo-controlled trial. Lancet 378: 403-11.
14. Beekman AT, Copeland JR, Prince MJ (1999) Review of community prevalence of depression in later life. British Journal of Psychiatry 174: 307-11.
15. Beekman AT, Geerlings SW, Deeg DJ, et al (2002) The natural history of late-life depression: a 6-year prospective study in the community. Archives of General Psychiatry 59: 605-11.
16. Bondareff W, Alpert M, Friedhoff AJ, et al (2000) Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. American Journal of Psychiatry 157: 729-36.
17. Bose A, Li D, Gandhi C (2008) Escitalopram in the acute treatment of depressed patients aged 60 years or older. American Journal of Geriatric Psychiatry 16: 14-20.
18. Brown MN, Lapane KL, Luisi AF (2002) The management of depression in older nursing home residents. Journal of the American Geriatric Society 50: 69-76.
19. Carney S, Geddes J (2003) Electroconvulsive therapy. BMJ 326: 1343-4.
20. Ciechanowski P, Wagner E, Schmaling K, et al (2004) Communityintegrated home-based depression treatment in older adults: a randomized controlled trial. JAMA 291: 1569-77.
21. Cipriani A, Furukawa TA, Salanti G, et al (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multipletreatments meta-Analysis. Lancet 373: 746-58.
22. Cipriani A, La Ferla T, Furukawa TA, et al (2010) Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews 14(4): CD006117.
23. Coupland C, Dhiman P, Morriss R, et al (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343: d4551.
24. Dew MA, Whyte EM, Lenze EJ, et al (2007) Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. American Journal of Psychiatry 164: 892-9.
25. Djernes JK, Gulmann NC, Foldager L, et al (2011) 13 year follow up of morbidity, mortality and use of health services among elderly depressed patients and general elderly populations. Australian and New Zealand Journal of Psychiatry 45: 654-62.
26. Dodd S, Horgan D, Malhi GS, et al (2005) To combine or not to combine? A literature review of antidepressant combination therapy. Journal of Affective Disorders 89: 1-11.
27. Fayssoil A, Issi J, Guerbaa M, et al (2011) Torsade de pointes induced by citalopram and amiodarone. Annales de Cardiologie et d'Angéiologie (Paris) 60: 165-8.
28. Howland RH (2011) A critical evaluation of the cardiac toxicity of citalopram: part 1. Journal of Psychosocial Nursing and Mental Health Services 49(11): 13-6.
29. Jung YE, Jun TY, Kim KS, et al (2011) Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder. International Journal of Clinical Pharmacology and Therapeutics 49: 437-43.
30. Kalu UG, Sexton CE, Loo CK, et al (2012) Transcranial direct current stimulation in the treatment of major depression: a meta-Analysis. Psychological Medicine 42: 1791-800.
31. Kasper S, de Swart H, Friis Andersen H (2005) Escitalopram in the treatment of depressed elderly patients. American Journal of Geriatric Psychiatry 13: 884-91.
32. Kennedy SH, Milev R, Giacobbe P, et al (2009) Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. Journal of Affective Disorders 117 (suppl 1): S44-53.
33. Kivela SL, Luukinen H, Koski K, et al (1998) Early loss of mother or father predicts depression in old age. International Journal of Geriatric Psychiatry 13: 527-30.
34. Knight BG (2009) Psychotherapy and Older Adults Resource Guide (online only). American Psychological Association (http://www.apa.org/pi/aging/ resources/guides/psychotherapy.aspx).
35. Kok R, Heeren T, Nolen W (2011) Continuing treatment of depression in the elderly: a systematic review and meta-Analysis of double-blinded randomized controlled trials with antidepressants. American Journal of Geriatric Psychiatry 19: 249-55.
36. Krishna M, Jauhari A, Lepping P, et al (2011) Is group psychotherapy effective in older adults with depression? A systematic review. International Journal of Geriatric Psychiatry 26: 331-40.
37. Lenox-Smith AJ, Jiang Q (2008) Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. International Clinical Psychopharmacology 23: 113-9.
38. Llewellyn-Jones RH, Baikie KA, Smithers H, et al (1999) Multifaceted shared care intervention for late life depression in residential care: randomised controlled trial. BMJ 319: 676-82.
39. Loo CK, Alonzo A, Martin D, et al (2012) Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial. British Journal of Psychiatry 200: 52-9.
40. Mark TL, Joish VN, Hay JW, et al (2011) Antidepressant use in geriatric populations: the burden of side effects and interactions and their impact on adherence and costs. American Journal of Geriatric Psychiatry 19: 211-21.
41. McDougall FA, Matthews FE, Kvaal K, et al (2007) Prevalence and symptomatology of depression in older people living in institutions in England and Wales. Age and Ageing, 36: 562-8.
42. Meyers BS, Flint AJ, Rothschild AJ, et al (2009) A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Archives of General Psychiatry 66: 838-47.
43. Morghen S, Gentile S, Ricci E, et al (2011) Rehabilitation of older adults with hip fracture: cognitive function and walking abilities. Journal of the American Geriatric Society 59: 1497-502.
44. Nelson J.C., Delucchi K., Schneider L.S. Efficacy of second generation antidepressants in late-life depression: A meta-Analysis of the evidence. American Journal of Geriatric Psychiatry, 2008, 16, 558-567.
45. Nelson J, Devanand D (2011) A systematic review and meta-Analysis of placebo-controlled antidepressant studies in people with depression and dementia. Journal of the American Geriatrics Society 59: 577-85.
46. National Collaborating Centre for Mental Health (2006) Dementia: Supporting People with Dementia and Their Carers in Health and Social Care (NICE Clinical Guideline 42). National Institute for Health and Clinical Excellence.
47. National Collaborating Centre for Mental Health (2009a) Depression: The Treatment and Management of Depression in Adults (Updated Edition) (National Clinical Practice Guideline 90). British Psychological Society/Royal College of Psychiatrists.
48. National Collaborating Centre for Mental Health (2009b) Depression in Adults with a Chronic Physical Health Problem: Treatment and Management (National Clinical Practice Guideline 91). British Psychological Society/Royal College of Psychiatrists.
49. O'Connor DW, Gardner B, Presnell I, et al (2010) The effectiveness of continuation-maintenance ECT in reducing depressed older patients' hospital re-Admissions. Journal of Affective Disorders 120: 62-6.
50. Reynolds CF, Frank E, Perel JM, et al (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA 281: 39-45.
51. Reynolds CF, Dew MA, Pollock BG, et al (2006) Maintenance treatment of major depression in old age. New England Journal of Medicine 354: 1130-8.
52. Reynolds CF, Dew MA, Martire LM, et al (2010) Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management. International Journal of Geriatric Psychiatry 25: 1134-41.
53. Reynolds CF, Butters MA, Lopez O, et al (2011) Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Archives of General Psychiatry 68: 51-60.
54. Roose SP, Miyazaki M, Devanand D, et al (2004) An open trial of venlafaxine for the treatment of late-life atypical depression. International Journal of Geriatric Psychiatry 19: 989-94.
55. Roose SP, Schatzberg AF (2005) The efficacy of antidepressants in the treatment of late-life depression. Journal of Clinical Psychopharmacology 25 (suppl 1): S1-7.
56. Rosenberg PB, Drye LT, Martin BK, et al (2010) Sertraline for the treatment of depression in Alzheimer disease. American Journal of Geriatric Psychiatry 18: 136-45.
57. Rush AJ, Trivedi MH, Wisniewski SR, et al (2006) Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine 354: 1231-42.
58. Rush AJ (2007) STAR *D: what have we learned? American Journal of Psychiatry 164: 201-4.
59. Rush AJ, Trivedi MH, Stewart JW, et al (2011) Combining medications to enhance depression outcomes (CO-MED): acute and long-Term outcomes of a single-blind randomized study. American Journal of Psychiatry 168: 689-701.
60. Sacchetti E, Trifiro G, Caputi A, et al (2008) Risk of stroke with typical and atypical anti-sychotics: a retrospective cohort study including unexposed subjects. Journal of Psychopharmacology 22: 39-46.
61. Sackeim HA, Dillingham EM, Prudic J, et al (2009) Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-Term efficacy and adverse effects. Archives of General Psychiatry 66: 729-37.
62. Schwarzbach M, Luppa M, Sikorski C, et al (2013) The relationship between social integration and depression in non-demented primary care patients ages 75 years and older. Journal of Affective Disorders 145: 172-8.
63. Scogin F, McElreath L (1994) Efficacy of psychosocial treatments for geriatric depression: a quantitative review. Journal of Consulting and Clinical Psychology 62: 69-74.
64. Seitz DP, Gill SS, Conn DK (2010) Citalopram versus other antidepressants for late-life depression: a systematic review and meta-Analysis. International Journal of Geriatric Psychiatry 25: 1296-305.
65. Sirey JA, Bruce ML, Alexopoulos GS (2005) The Treatment Initiation Program: an intervention to improve depression outcomes in older adults. American Journal of Psychiatry 162: 184-6.
66. Steptoe A, Marmot M (2003) Burden of psychosocial adversity and vulnerability in middle age: associations with biobehavioral risk factors and quality of life. Psychosomatic Medicine 65: 1029-37.
67. Steunenberg B, Beekman AT, Deeg DJ, et al (2007) Mastery and neuroticism predict recovery of depression in later life. American Journal of Geriatric Psychiatry 15: 234-42.
68. Teri L, Logsdon RG, Uomoto J, et al (1997) Behavioral treatment of depression in dementia patients: a controlled clinical trial. Journals of Gerontology, Series B: Psychological Sciences and Social Sciences 52: P159-66.
69. Teri L, Gibbons LE, McCurry SM, et al (2003) Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 290: 2015-22.
70. Tew JD, Mulsant BH, Haskett RF, et al (1999) Acute efficacy of ECT in the treatment of major depression in the old-old. American Journal of Psychiatry 156: 1865-70.
71. Thase ME, Friedman ES, Biggs MM, et al (2007) Cognitive therapy versus medication in augmentation and switch strategies as secondstep treatments: a STAR *D report. American Journal of Psychiatry 164: 739-52.
72. Turnheim K (2003) When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Experimental Gerontology 38: 843-53.
73. Volicer L, Frijters DH, Van der Steen JT (2012) Relationship between symptoms of depression and agitation in nursing home residents with dementia. International Journal of Geriatric Psychiatry 27: 749-54.
74. Waring WS, Graham A, Gray J, et al (2010) Evaluation of a QT nomogram for risk assessment after antidepressant overdose. British Journal of Clinical Pharmacology 70: 881-5.
75. Watanabe N, Omori IM, Nakagawa A, et al (2011) Mirtazapine versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews issue 12: CD006528.
76. Weintraub D, Rosenberg PB, Drye LT, et al (2010) Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. American Journal of Geriatric Psychiatry 18: 332-40.
77. Wilkins V, Kiosses D, Ravdin L (2010) Late-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions. Clinical Interventions in Aging 5: 323-31.
78. Wilson KC, Mottram PG, Vassilas CA (2008) Psychotherapeutic treatments for older depressed people. Cochrane Database of Systematic Reviews (1): CD004853.
79. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO.